Gencor rebrands to Saanroo, will operate as separate nutraceutical division

Gencor (Austin, TX) has announced that it will be rebranding to Saanroo, reflecting the company’s renewed commitment to deliver innovative, evidence-based ingredients for nutraceuticals, cosmeceuticals, practitioners, and functional food and beverages. The rebrand means that Sanroo will operate as a nutraceutical division while Gencor Pacific will continue to operate as a pharmaceutical arm.

“Saanroo represents the next chapter in our journey—a brand built on proof, not promises,” said John Quilter, CEO of Saanroo, in a press release. “Our mission is simple yet powerful: to help people live longer, healthier lives through wellness that is truly proven.”

According to the company’s press release, Saanroo comes from the Tamil word “sanru.” Tamil is the language of the Indian state Tamil Nadu. This is where the Gencor founders originate from, and a place that they say inspired the company’s success for the past 25 years. “We altered the vowels to improve the pronunciation of ‘Saan’ plus the suffix ‘roo,’ which signifies lightness and memorability,” the press release explains. “This modern yet rooted meaning translates to ‘Proof, Testimony, Evidence.’”

The new logo is also very intentional, says Saanroo. The series of dot molecules that form the “S,” for example, symbolize movement, connection, and constant evolution. The circular marks are also deliberately imperfect , expressing the realistic organic quality that reflects the Saanroo ethos. Additionally, the colors blend visual identity and the company’s various aspects, such as “blue for its pharmaceutical history, green for its leadership in nutraceuticals, and yellow for its delivery innovation and technology.”

“We are so proud to launch our nutraceutical division as a separate company,” said Ramasamy Venkatesh, Managing Director of Gencor Pacific. “This move marks a strategic expansion in bridging the scientific integrity of pharmaceuticals and nutraceuticals to deliver safe, innovative, and efficacious ingredient solutions for our customers and partners.”

The rebrand coincides with SupplySide Global 2025 where the company is showcasing a number of innovative nutraceutical solutions. This includes a water dispersible berberine called BioBerb. “BioBerb is not just another supplement; it’s a smarter, more advanced way to support your health. If you're serious about optimizing your energy, blood sugar, and overall metabolic function, BioBerb is a clear choice,” said George Kokkinis, CEO of Pharmako Biotechnologies, in a press release.

They are also unveiling new data on its proprietary Oleoylethanolamide (OEA) ingredient, Trpti, demonstrating its influence on weight management through the gut microbiome and through its effect on GLP-1 secretion and inhibition of DPP-4. OEA is also combined with LipiSperse delivery technology to make it highly bioavailable.

“At Gencor, innovation begins with science that genuinely impacts how people feel and perform," said John Quilter, CEO of Gencor, in a press release. "With BioBerb, Trpti, and Levagen, we’re pushing the limits of what’s possible in natural metabolic and joint health support. These ingredients demonstrate our ongoing commitment to turning advanced clinical research into effective, accessible wellness solutions for today’s active consumers."

Don’t miss an education session featuring researchers Dr. Amanda Rao from RDC Global and Dr. Daniele Piomelli, PharmD, PhD, MD (h.c.). director of the University of California Center for the Study of Cannabis & Cannabinoid Research and Rhizotomos Consulting. In the 50 minute presentation Rao will present new research on BioBerb and Piomelli will share bioavailability data on Trpti and its role in supporting metabolic health. That session will be on October 29, 2025 from 4-4:50PM at the product development theater, booth #8076, Bayside B, Level 1.